Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 2SANOFI PASTEUR LIMITED
02 2ASTRAZENECA CANADA INC
03 1GLAXOSMITHKLINE INC
01 3HAEMOPHILUS INFLUENZAE TYPE B-PRP
02 1INFLUENZA VIRUS TYPE B (VICTORIA)
03 1INFLUENZA VIRUS TYPE B (YAMAGATA)
01 1KIT
02 2SPRAY
03 2SUSPENSION
01 1ACT-HIB
02 2FLUMIST QUADRIVALENT
03 1INFANRIX HEXA
04 1PENTACEL
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Canada
HAEMOPHILUS INFLUENZAE TYPE B-PRP
Brand Name : ACT-HIB
Dosage Form : KIT
Dosage Strength : 10MCG/0.5ML
Packaging : 5X1VIAL - 5X0.5ML AMP
Approval Date :
Application Number : 1959034
Regulatory Info :
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Canada
HAEMOPHILUS INFLUENZAE TYPE B-PRP
Brand Name : PENTACEL
Dosage Form : SUSPENSION
Dosage Strength : 10MCG/0.5ML
Packaging :
Approval Date :
Application Number : 2534797
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
INFLUENZA VIRUS TYPE B (VICTORIA)
Brand Name : FLUMIST QUADRIVALENT
Dosage Form : SPRAY
Dosage Strength : 32000000FFU/0.2ML
Packaging :
Approval Date :
Application Number : 2426544
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
INFLUENZA VIRUS TYPE B (YAMAGATA)
Brand Name : FLUMIST QUADRIVALENT
Dosage Form : SPRAY
Dosage Strength : 32000000FFU/0.2ML
Packaging :
Approval Date :
Application Number : 2426544
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
HAEMOPHILUS INFLUENZAE TYPE B-PRP
Brand Name : INFANRIX HEXA
Dosage Form : SUSPENSION
Dosage Strength : 10MCG/0.5ML
Packaging : 10X0.5ML
Approval Date :
Application Number : 2253852
Regulatory Info :
Registration Country : Canada
